Sirnaomics
Clinical trials sponsored by Sirnaomics, explained in plain language.
-
Can a single injection silence a clotting protein and prevent strokes?
Disease control OngoingThis trial tests an experimental drug called FXI-GalNAc-siRNA, which uses RNA technology to temporarily lower a clotting protein in the blood. The goal is to see if a single injection is safe and how the body processes it in healthy adults aged 18 to 55. If it works, this approac…
Phase: PHASE1 • Sponsor: Sirnaomics • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a Gene-Targeting injection make hypertrophic scars fade?
Symptom relief TerminatedThis trial investigates whether STP705, an injection that uses small interfering RNA to block scar-promoting proteins, can safely improve hypertrophic scars. Adults aged 18 to 45 with linear hypertrophic scars will receive weekly injections into the scar for four weeks. The study…
Phase: PHASE1, PHASE2 • Sponsor: Sirnaomics • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC